The TFOS DEWS 3 report of Summer 2025 gives us the best peer reviewed information to date to manage dry eye and ocular surface disease in practice.But what happens when the patients condition goes beyond what you would traditionally offer in high street practice? What else is available?This session will explore the more advanced technology available for managing these patients as well as what medicinal interventions are available and when we should intervene with them. How can being IP qualified aid you in helping the patient the less straightforward patients.